#Sofinnova Partners
Coverage of Sofinnova Partners focuses on the firm’s venture capital activity, with attention to its investments, fund strategy, and role in supporting startups across healthcare, life sciences, and deep tech. Articles in this archive highlight how the firm fits into broader startup and AI-adjacent innovation trends.
Sofinnova closes €725M Crossover II fund in Europe
Sofinnova Partners closed its €725 million Crossover II fund to back later-stage European biopharma and medtech companies.
Nov 18, 2026 · 3 min
Galvanize raises $130M Series D led by HealthQuest
Galvanize Therapeutics closed an oversubscribed $130 million Series D to expand Aliya, advance RheOx, and build its next PEF platform.
Nov 17, 2026 · 3 min